Print Print Share Share #MISSING TRANSLATION: PageBar.SendToFriendTooltip# Email Large font-sizeNormal font-sizeSmall font-size

Reassessment of reimbursement status of medicinal products in ATC-groups A01, A04, C04, C05 and C10

In connection with the reassessment of the reimbursement status of medicinal products, the Reimbursement Committee discussed the reimbursement status of certain ATC groups at its meeting on 16 January 2007. The ATC groups concerned are:

  • A01, stomatological preparations, and A04, antiemetics and antinauseants (first discussion)
  • C04, peripheral vasodilators, and C05, vasoprotectives (draft for recommendations)
  • C10, lipid modifying agents (consultation replies received).

Via the fact box to the right, you can find material from the meeting.

For further information, please contact Elisabeth Thomsen, tel.: +45 4488 9306, or the Reimbursement Section, medicintilskud@dkma.dk .

The Danish Medicines Agency, 19 January 2007

Created 15 February 2007